Clinical Validation of the sFlt-1:PlGF Ratio as a Biomarker for Preeclampsia Diagnosis in a High-Risk Obstetrics Unit.
Jessica J MillerVictoria HigginsNir MelamedMichelle HladunewichLiyan MaPaul Siu Fai YipLei FuPublished in: The journal of applied laboratory medicine (2023)
Our study shows the superior clinical performance of sFlt-1:PlGF over hypertension and proteinuria alone to predict preeclampsia at a high-risk obstetrical unit.
Keyphrases